CC BY 4.0 · Arch Plast Surg 2023; 50(06): 573-577
DOI: 10.1055/s-0043-1771520
Hand/Peripheral Nerve
Case Report

Surgical Management of Pachyonychia Congenita in a 3-Year-Old

1   Division of Plastic Surgery, Department of Surgery, The University of Utah Hospital, Salt Lake City, Utah
,
1   Division of Plastic Surgery, Department of Surgery, The University of Utah Hospital, Salt Lake City, Utah
,
1   Division of Plastic Surgery, Department of Surgery, The University of Utah Hospital, Salt Lake City, Utah
,
1   Division of Plastic Surgery, Department of Surgery, The University of Utah Hospital, Salt Lake City, Utah
,
1   Division of Plastic Surgery, Department of Surgery, The University of Utah Hospital, Salt Lake City, Utah
,
1   Division of Plastic Surgery, Department of Surgery, The University of Utah Hospital, Salt Lake City, Utah
,
1   Division of Plastic Surgery, Department of Surgery, The University of Utah Hospital, Salt Lake City, Utah
› Author Affiliations
Funding None.

Abstract

Pachyonychia congenita is a rare genetic disorder characterized by hypertrophic nail plates, hyperkeratotic nail beds, and thickened hyponychium of the fingers and toes, impairing manual dexterity and resulting in poor aesthetics. The current body of literature describes various treatment modalities, but no singular approach has been defined as the gold standard. In this case, the authors employed different surgical techniques for treating pachyonychia congenita to evaluate the most effective approach. A 3-year-old boy presented with hypertrophic nail growth involving all digits of both hands and feet. Three surgical procedures were performed on the patient's fingers and toes using germinal matrix excision (GME) alone, GME plus partial sterile matrix excision (pSME), or GME plus complete sterile matrix excision (cSME). The digits treated with GME + cSME exhibited no recurrence of nail growth. Those treated with GME alone exhibited recurrence of hypertrophic nail growth, although their growth slowed. Excision of GME + cSME prevented recurrence of hypertrophic nails, while GME alone or with pSME led to slower-growing hypertrophic nails. Complete excision of the germinal and sterile matrices with skin graft closure may be a definitive treatment for pachyonychia congenita, but further studies are needed to validate these findings.

Authors' Contributions

All authors contributed equally to the concept, writing, and submission process of this manuscript.


Ethical Approval

This project was deemed exempt from IRB approval per local institution guidelines.


Patient Consent

Written patient consent was obtained for this study.




Publication History

Received: 03 November 2022

Accepted: 15 June 2023

Article published online:
21 December 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Wu AG, Lipner SR. Distinctions in the management, patient impact, and clinical profiles of pachyonychia congenita subtypes. Skin Appendage Disord 2021; 7 (03) 194-202
  • 2 Milstone LM, Fleckman P, Leachman SA. et al. Treatment of pachyonychia congenita. J Investig Dermatol Symp Proc 2005; 10 (01) 18-20
  • 3 Goldberg I, Fruchter D, Meilick A, Schwartz ME, Sprecher E. Best treatment practices for pachyonychia congenita. J Eur Acad Dermatol Venereol 2014; 28 (03) 279-285
  • 4 Daroach M, Dogra S, Bhattacharjee R, Tp A, Smith F, Mahajan R. Pachyonychia congenita responding favorably to a combination of surgical and medical therapies. Dermatol Ther 2019; 32 (05) e13045
  • 5 Rohold AE, Brandrup F. Pachyonychia congenita: therapeutic and immunologic aspects. Pediatr Dermatol 1990; 7 (04) 307-309
  • 6 Thomsen RJ, Zuehlke RL, Beckman BI. Pachyonychia congenita: surgical management of the nail changes. J Dermatol Surg Oncol 1982; 8 (01) 24-28
  • 7 Soderquist NA, Reed WB. Pachyonychia congenita with epidermal cysts and other congenital dyskeratoses. Arch Dermatol 1968; 97 (01) 31-33
  • 8 Jackson AD, Lawler SD. Pachyonychia congenita; a report of six cases in one family, with a note on linkage data. Ann Eugen 1951; 16 (01) 142-146
  • 9 Wright CS, Guequirre JP. Pachyonychia congenita; report of two cases, with studies on therapy. Arch Derm Syphilol 1947; 55 (06) 819-827
  • 10 Cosman B, Symonds Jr FC, Crikelair GF. Plastic surgery in pachyonychia congenita and other dyskeratoses. Case report and review of the literature. Plast Reconstr Surg 1964; 33: 226-236
  • 11 White IV RR, Noone RB. Pachyonychia congenita (Jadassohn-Lewandowski syndrome: case report. Plast Reconstr Surg 1977; 59 (06) 855-858
  • 12 Anderson JH, Greig JD, Ireland AJ, Anderson JR. Randomized, prospective study of nail bed ablation for recurrent ingrowing toenails. J R Coll Surg Edinb 1990; 35 (04) 240-242
  • 13 Grieg JD, Anderson JH, Ireland AJ, Anderson JR. The surgical treatment of ingrowing toenails. J Bone Joint Surg Br 1991; 73 (01) 131-133
  • 14 DeKlotz CMC, Schwartz ME, Milstone LM. Nail removal in pachyonychia congenita: patient-reported survey outcomes. J Am Acad Dermatol 2017; 76 (05) 990-992